XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

 

   As of June 30, 2024   Fair Value Measurements 
       Fair   As of June 30, 2024 
   Amount   Value   Level 1   Level 2   Level 3 
                     
Liabilities:                                    
Contingent consideration:                         
Asuragen (1)  $30   $30   $-   $-   $30 
Note payable:                         
BroadOak loan   7,400    6,784    -    -    6,784 
   $7,430   $6,814   $-   $-   $6,814 

 

(1) See Note 9, Other Accrued Expenses

 

   As of December 31, 2023   Fair Value Measurements 
   Carrying   Fair   As of December 31, 2023 
   Amount   Value   Level 1   Level 2   Level 3 
Liabilities:                                   
Contingent consideration:                         
Asuragen (1)  $453   $453   $-   $-   $453 
Note payable:                         
BroadOak loan   10,000    9,343    -    -    9,343 
   $10,453   $9,796   $-   $-   $9,796 

 

(1) See Note 9, Other Accrued Expenses
SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

A roll forward of the carrying value of the Contingent Consideration Liability and BroadOak Loan to June 30, 2024 is as follows:

 

                   Adjustment     
   December 31,
2023
   Payments   Transferred
to Accrued
Expenses
   Accretion/
Interest Accrued
   to Fair Value/
Mark to
Market
   June 30,
2024
 
                         
Asuragen  $453   $-   $(453)  $            30   $-   $30 
                               
BroadOak loans   9,343    (2,600)   -    -    41    6,784 
                               
   $9,796   $(2,600)  $(453)  $30   $41   $6,814